Prime Medicine, Inc. (PRME)
3.80
-0.04
(-1.04%)
USD |
NASDAQ |
Nov 20, 10:10
Prime Medicine Free Cash Flow : -158.54M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -158.54M |
| June 30, 2026 | -156.85M |
| March 31, 2026 | -158.74M |
| December 31, 2025 | -167.10M |
| September 30, 2025 | -115.10M |
| June 30, 2025 | -107.00M |
| March 31, 2025 | -111.41M |
| December 31, 2024 | -130.16M |
| September 30, 2024 | -190.32M |
| June 30, 2024 | -205.20M |
| Date | Value |
|---|---|
| March 31, 2024 | -200.61M |
| December 31, 2023 | -174.14M |
| September 30, 2023 | -163.96M |
| June 30, 2023 | -156.77M |
| March 31, 2023 | -139.00M |
| December 31, 2022 | -147.92M |
| September 30, 2022 | -125.96M |
| June 30, 2022 | -102.50M |
| March 31, 2022 | -84.82M |
| December 31, 2021 | -38.23M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intellia Therapeutics, Inc. | -358.08M |
| Beam Therapeutics, Inc. | -398.24M |
| Twist Bioscience Corp. | -95.96M |
| Moderna, Inc. | -2.044B |
| Q32 Bio, Inc. | -20.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -36.68M |
| Cash from Investing (Quarterly) | 41.25M |
| Cash from Financing (Quarterly) | 2.868M |
| Free Cash Flow Per Share (Quarterly) | -0.2079 |
| Free Cash Flow to Equity (Quarterly) | -34.92M |
| Free Cash Flow to Firm (Quarterly) | -36.98M |
| Free Cash Flow Yield | -23.00% |